Intraosseous Infusion Devices Market Analysis & Forecast: 2026-2033

Global Intraosseous Infusion Devices Market Size and Forecast – 2026 To 2033

The global intraosseous infusion devices market is expected to grow from USD 600.1 Mn in 2026 to USD 972.6 Mn by 2033, registering a compound annual growth rate (CAGR) of 7.1% from 2026 to 2033.  The market for intraosseous infusion devices is poised for significant expansion, fueled by the rising number of trauma-related injuries, cardiac emergencies, and critical care instances that demand quick vascular access.

According to the World Health Organization, of the 4.4 million injury-related deaths, unintentional injuries take the lives of 3.16 million people every year and violence-related injuries kill 1.25 million people every year. Roughly 1 in 3 of these deaths result from road traffic crashes, 1 in 6 from suicide, 1 in 10 from homicide and 1 in 61 from war and conflict.

(Source: World Health Organization)

Key Takeaways of the Global Intraosseous Infusion Devices Market

• Manual is projected to hold 43.1% of the global intraosseous infusion devices market share in 2026, making it the dominant type segment. The segment shows dominance in North America since emergency response organizations and trauma systems keep preferring the use of lightweight and portable devices when dealing with mass casualty situations and prehospital emergencies. Manual systems are highly favored in the rural setting in emergency medical services (EMS) and military settings due to their easy portability and minimal maintenance needs. For instance, Emergency Medical Operations Guidance of the U.S. Federal Emergency Management Agency (FEMA) emphasized the need for rapid field stabilization capabilities among disaster-response medical personnel, encouraging the sustained use of manually driven emergency access devices. (Source: U.S. Department of Homeland Security)
• Proximal tibia is projected to hold 27.5% of the global intraosseous infusion devices market share in 2026, making it the dominant access site segment across Europe due to its wide use in pediatric emergency medicine as well as emergency treatment of traumatized patients when physicians need rapid anatomical localization of veins under stressful conditions. The choice of the tibial vein is favored by pre-hospital European practitioners due to the simplicity of patient positioning. For instance, the National Health Service (NHS) Clinical Guidelines for Intraosseous Access states that tibial intraosseous placement is a widely used technique for gaining access during emergencies within critical care protocols in the U.K.'s emergency services. (Source: National Health Service)
• The adults segment is projected to hold 38.8% of the global intraosseous infusion devices market share in 2026, making it the dominant age segment, with high penetration in North America, owing to the prevalence of overdose cases of opioids, cardiovascular emergencies, and multiple trauma cases that need immediate vascular access in emergency rooms. The practice of using intraosseous fluids for adult critical care is gaining traction, especially when venous access fails in an unresponsive patient. For instance, National Institute on Drug Abuse (NIDA) Overdose Surveillance Report highlights numerous cases of overdose emergencies in various parts of the region, particularly the U.S., resulting in greater usage of rapid access resuscitation such as intraosseous infusion techniques. (Source: National Institute on Drug Abuse)
• North America maintains its dominance with an estimated share of 39.4%in 2026, because of the large number of emergency interventions and the already developed trauma care systems, along with the prevalence of the intraosseous technique in Advanced Cardiac Life Support (ACLS) in the U.S. and Canada. The region also benefits from robust preparedness for emergencies and growing popularity of the intraosseous technique among paramedics during out-of-hospital cardiac arrests. For instance, American Heart Association, Advanced Cardiac Life Support (ACLS) guidelines advocate for intraosseous access in situations where intravenous access cannot be quickly secured during resuscitation, making its use widespread throughout North America emergency care. (Source: American Heart Association)
• Asia Pacific is expected to exhibit the fastest growth with an estimated contribution of 20.5% share in 2026, as a result of growing incidence of road accidents, development of emergency healthcare infrastructure, and growth in pre-hospital care facilities in densely populated nations like India and China. Governments in the area are enhancing trauma and emergency services to save lives due to severe injuries and cardiac cases. For instance, India’s National Ambulance Service (108 Emergency Response Service) continues to grow the network of emergency transport in various Indian states, thus creating a high demand for faster methods of vascular access in prehospital settings. (Source: Ministry of Health and Family Welfare)
• Rising adoption of intraosseous access in military and disaster medicine: Intraosseous infusion technology is becoming more popular among military medical personnel during combat situations, disasters, and mass casualties where there is a need for speedy vascular access when other means such as venipuncture are impossible. The armed forces and first responders are opting for intraosseous devices because they allow fast medication and fluid delivery within a short period without many preparations. The growing demand for battlefield trauma treatment and disaster preparation training will lead to the market expansion.
• Increasing integration of intraosseous devices in air ambulance and prehospital emergency care: With increasing usage of helicopter emergency medical services (HEMS) and ambulances for emergency medicine services, there will be an increased need for portable and user-friendly intraosseous infusion devices. Increasingly, paramedics and emergency medical technicians are trained to use intraosseous infusions in cases of cardiac arrest, trauma, and pediatric emergencies due to the time factor before reaching the hospital. The development of pre-hospital care facilities in developing and developed nations are anticipated to contribute to the market growth.

Segmental Insights

To learn more about this report, Request Free Sample

Why Does the Manual Segment Dominate the Global Intraosseous Infusion Devices Market?

Manual is projected to hold a market share of 43.1% in 2026, because of its reduced costs, easy operating procedure, and universal application in emergencies and other limited resources. Such devices have great popularity among ambulances, military healthcare centers, and healthcare facilities that cannot afford advanced equipment. Manual devices involve less maintenance, use no batteries or charge, which makes them convenient for emergency situations. For instance, Cook Medical Dieckmann Intraosseous Infusion Needle is created in order to ensure fast and efficient intraosseous access for infusion of liquids and drugs in emergencies where IV access is either difficult or delayed. (Source: Cook Medical) The sustained availability of cost-effective manual intraosseous systems are aiding their widespread uptake globally.

Why Does Proximal Tibia Represent the Largest Access Site Segment in the Global Intraosseous Infusion Devices Market?

To learn more about this report, Request Free Sample

Proximal tibia is projected to hold a market share of 27.5% in 2026, attributed to the ease of anatomic access, first-pass success rate, and rapid insertion in emergency cases, like cardiac arrest, injury, and dehydration cases. This site presents little soft tissue coverage and landmark identification, making it possible for the clinicians to gain immediate vascular access irrespective of the condition of the patient. According to research published by ResearchGate, proximal tibial intraosseous (IO) access proves more convenient and efficient as compared to humeral access, especially for paramedics and in emergency care scenarios. (Source: ResearchGate)

Furthermore, the proximal tibia makes up the commonest choice in emergency care centers and emergency medical technician services due to reduced risks of needle dislodgment and reliable infusion. For instance, a review article from the British Association of Critical Care Nurses, the proximal tibia was identified as the preferred intraosseous access point due to its simplicity, speed, and lower incidence of failed attempts relative to other access points. (Source: University of Huddersfield)

Adults Segment Dominates the Global Intraosseous Infusion Devices Market

The adults segment is projected to hold a market share of 38.8% in 2026, due to an increasing incidence of trauma, cardiac arrest, sepsis, and emergency surgeries. Peripheral venous access is not feasible in adult patients due to the occurrence of obesity, low blood pressure, blood loss, or vascular collapse. Therefore, intraosseous access serves as an alternative route in emergencies. The market segment is driven by an increasing adoption of advanced cardiac life support techniques and growing utilization of intraosseous devices in hospitals such emergency departments, intensive care units, and ambulance services.

Moreover, medical practitioners favor the use of intraosseous infusions in adult patients due to rapid fluid administration, medication delivery, and higher success rates on their first attempt in case of failure to establish peripheral venous access in emergencies. For instance, a systematic review conducted and presented by the National Library of Medicine indicated the increasing trend towards intraosseous access in adult emergency situations due to rapidity, efficiency, and efficacy. (Source: National Library of Medicine)

Currents Events and their Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

(Source: Food and Drug Administration, European Commission)

Global Intraosseous Infusion Devices Market Dynamics

To learn more about this report, Request Free Sample

Market Drivers

Increasing prevalence of cardiac arrest and critical care emergencies requiring immediate vascular access

The increasing occurrence of heart attack along with other serious cases where a rapid vascular access is needed have led to an increase in the demand for intraosseous infusion devices. These types of devices are commonly used when resuscitating patients or dealing with other emergencies where intravenous access is difficult. According to World Health Organization, an estimated 19.8 million people died from cardiovascular diseases in 2022, representing approximately 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. (Source: World Health Organization) Furthermore, according to Centers for Disease Control and Prevention, Cardiac Arrest Statistics, more than 356,000 people have an out-of-hospital cardiac arrest in the U.S. every year, and about 60% to 80% of them die before reaching the hospital. (Source: Centers for Disease Control and Prevention), highlighting the need for rapid vascular access technologies in emergency and critical care settings.

Growing adoption in emergency medical services (EMS) and military healthcare

The rising use of intraosseous infusion devices in the field of emergency medicine services and military medicine will significantly contribute to the overall growth of the market owing to the high demand for fast vascular access in cases of trauma, battlefield injuries, cardiac arrests, and emergencies. There is an increasing tendency among emergency medical service providers and military medical staff to integrate the use of intraosseous infusion technology into advanced life support practices for the fast delivery of fluid and medication when IV access is not easily available. One of the prominent players, Cook Medical Emergency Medicine Solutions, is continually expanding its portfolio of emergency vascular access devices that are applicable in trauma and critical care environments.

For example, the company provides innovative products for emergency medicine applications that have been developed specifically to facilitate rapid vascular access in acutely ill patients, thus ensuring the wider use of intraosseous technology in emergency situations. (Source: Cook Medical) With the increasing use of advanced emergency medical equipment technology among both ambulances and militaries, the widespread use of intraosseous infusion technology continues to grow.

Emerging Trends

• Increasing Adoption of Powered and Battery-Operated Intraosseous Devices: There has been an increase in the utilization of powered intraosseous infusion systems among healthcare practitioners owing to their ability to provide fast insertion, precision in procedure, and ease of use especially in emergencies. There is increasing attention by device makers towards manufacturing portable intraosseous infusion devices.
• Growing Integration of Intraosseous Access in Pre-Hospital Emergency Care: The use of intraosseous infusion sets in administering advanced life support for emergency medical service (EMS) ambulances has gained more popularity. The need for emergency preparedness in providing quick trauma care has made the use of intraosseous vascular access sets popular around the world.

Regional Insights

To learn more about this report, Request Free Sample

Why is North America a Strong Market for Intraosseous Infusion Devices?

North America leads the global intraosseous infusion devices market, accounting for an estimated 39.4% share in 2026, owing to the increasing adoption of technological innovations within emergency care procedures conducted in trauma centers, air ambulances, and combat casualty care units. The application of technological innovation within the North America region aims at increasing the effectiveness of vascular access in emergencies through advanced infusion devices. For instance, SAM Medical continues to adopt an increased number of SAM IO intraosseous access system within emergency applications in the U.S. to ensure effective fluid delivery in emergency scenarios. (Source: SAM Medical) Moreover, regional healthcare providers are including intraosseous access protocols in advanced life support training programs, further reinforcing the use of the product in emergency medicine scenarios.

Why Does the Asia Pacific Intraosseous Infusion Devices Market Exhibit High Growth?

The Asia Pacific intraosseous infusion devices market is expected to exhibit the fastest growth with an estimated contribution of 20.5% share to the market in 2026, owing to the development of emergency healthcare infrastructures and adoption of advanced critical care technologies in emerging countries. Countries like China, India, and Japan are enhancing their trauma care programs, ambulance systems, and emergency medical service operations, which results in a need for advanced rapid vascular access products. Furthermore, disaster management and training in emergency medicine are aiding in promoting intraosseous access technologies among healthcare settings. For instance, Pyng Medical Corp. (now part of Teleflex) FAST1 Intraosseous Technology is increasingly being promoted for use in military and emergency medical settings, leading to a rise in demand for advanced intraosseous access devices in healthcare markets globally, including those in the Asia Pacific region. (Source: Teleflex Incorporated)

Global Intraosseous Infusion Devices Market Outlook for Key Countries

Why is the U.S. Leading Innovation and Adoption in the Intraosseous Infusion Devices Market?

The U.S. has the potential for leadership in innovation and adoption in the field of intraosseous infusion devices due to the high product adoption rate owing to the presence of established medical device companies (such as Teleflex Incorporated, Becton, Dickinson and Company (BD), and Cook Medical) and constant development of new technologies in the field of emergency vascular access devices.

Several companies are working in the development of innovative products in terms of usability and portability of intraosseous access systems in emergency settings. The encouraging U.S. FDA policies and regulations (such as the FDA 510(k) Clearance Pathway and Breakthrough Devices Program) are also helping in increasing the approval rate of innovative medical devices and thereby driving the growth of this market. Additionally, the extensive use of intraosseous access systems in hospitals, emergency medical services (EMS), and military healthcare establishments are contributing positively to the market growth.

Is U.K. a Favorable Market for Intraosseous Infusion Devices?

The U.K. is an ideal market for intraosseous infusion devices attributed to the widespread use of highly sophisticated emergency care equipment in hospitals as well as in ambulance services. The existence of highly developed healthcare facilities and the rising emphasis on rapid vascular access techniques have led to the expansion of the market. Regulatory backing from the Medicines and Healthcare products Regulatory Agency (MHRA) has been helpful in promoting innovations in the development of emergency care devices in the country. Furthermore, the rising application of intraosseous access systems for trauma care, critical care, and pre-hospital emergency treatments has contributed to the growth of the market in the country.

Is China Emerging as a Key Growth Hub for the Intraosseous Infusion Devices Market?

The intraosseous infusion devices market in China is currently experiencing significant development attributed to the evolution of its healthcare infrastructure during emergencies as well as the introduction of advanced healthcare technology in hospitals and trauma centers. The application of rapid vascular access devices is also on the rise in cases of emergencies and in critical care units. The efforts of the National Medical Products Administration (NMPA) through regulation have been encouraging the adoption of new devices and technologies into the healthcare system. In addition, advancements being made in emergency medical services (EMS) and critical care units have been contributing to the growth of the market.

Why Does Germany Top the Europe Intraosseous Infusion Devices Market?

Germany dominates the intraosseous infusion devices market in Europe owing to the country’s advanced health care infrastructure and high adoption rates of emergency and critical care devices in hospitals and trauma centers (Germany has more than 1,900 hospitals, according to the Federal Statistical Office of Germany). There is an established network for emergency medical services in Germany, which facilitates the use of fast vascular access devices in pre-hospital and critical care scenarios. Regulations under the European Union Medical Device Regulation (EU MDR) are conducive to the adoption of technological advancements in intraosseous devices. Moreover, the presence of top medical devices manufacturers (such as Becton, Dickinson and Company (BD), Teleflex Incorporated, and Cook Medical) and increased attention towards emergency care advancements are fueling the market growth.

Is the Intraosseous Infusion Devices Market Developing in Japan?

Japan is gradually evolving into a prominent market for intraosseous infusion devices owing to the rising uptake of sophisticated emergency and critical care equipment at hospitals and healthcare facilities. The country’s commitment to technological advancements in medical devices and precision healthcare has led to the use of rapid vascular access devices in emergency medicine. Furthermore, the regulatory endorsement by the Pharmaceuticals and Medical Devices Agency (PMDA) has helped in promoting technologically advanced intraosseous systems. Besides, the rising use of intraosseous devices in trauma treatment, disaster relief operations, and emergency medical services (EMS) is aiding the growth of the market.

Regulatory Landscape Governing the Global Intraosseous Infusion Devices Market

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

How are technological advancements in battery-powered and user-friendly devices creating new growth opportunities in the global intraosseous infusion devices market?

Technology-enabled intraosseous infusion system devices that are battery-powered and easy-to-use are creating new growth opportunities in the global intraosseous infusion devices market owing to features like fast insertion, accuracy, portability, and usability during emergencies. Technological advancements in battery-operated devices enables health professionals to get rapid vascular access within few seconds in conditions that include trauma care, cardiac arrest, and other emergencies, where vascular access becomes difficult using traditional methods of infusion. The focus for manufactures in designing the device has been mainly on ergonomic devices, safety features, and portability for enhanced efficiency in emergencies. Moreover, technological advancements witnessed in the clinical sector have been pushing manufacturers to design advanced intraosseous devices.

For instance, a retrospective observational study conducted in December 2024 in the National Library of Medicine found that the safety and effectiveness of the Arrow EZ-IO System for pediatric emergency medicine is high and has no adverse events, which proves the increasing acceptance of intraosseous devices with innovative technology in clinical practice. (Source: National Library of Medicine) The continual advancement in the area of powered intraosseous access technologies are anticipated to improve the performance of emergency care systems and drive the market expansion.

Market Players, Key Development, and Competitive Intelligence

To learn more about this report, Request Free Sample

Key Developments

• In October 2024, BD unveiled its new intraosseous vascular access system that can help obtain fast vascular access in emergencies where intravenous access is difficult or not available. The product launch was part of BD’s emergency care product line, and it reflected the industry trend towards quicker intraosseous infusions in emergencies.
• In May 2024, Teleflex Incorporated launched the Arrow EZ-IO Intraosseous Access Procedure Tray, adding another product to its range of intraosseous vascular access products. This move was made in an effort to enhance procedural efficacy and rapid vascular access, helping Teleflex solidify its presence in the global intraosseous infusion device industry.

Competitive Landscape

The global intraosseous infusion devices market is moderately competitive due to the presence of well-known companies in the sector that emphasize the development of fast vascular access technology. Companies within the market continue to invest in innovations, drill-driven products, and portable intraosseous access products to increase their market share in hospitals, EMS services, and military healthcare markets. Other strategic initiatives being employed by companies to improve their market share include product launches and regulatory approvals. Key focus areas include:

• Development of lightweight, portable, and battery-powered intraosseous infusion systems
• Expansion of product portfolios for trauma care, EMS, and military applications
• Strengthening partnerships with hospitals, emergency response organizations, and defense agencies
• Increasing focus on user-friendly devices with faster insertion and improved safety mechanisms
• Strategic investments in training programs and global distribution network expansion

Market Report Scope

Intraosseous Infusion Devices Market Report Coverage

Analyst Opinion (Expert Opinion)

• The global intraosseous infusion devices market is projected to experience a stable growth rate owing to the growing incidences of trauma cases, cardiovascular accidents, and the rising need for speedy vascular access procedures. The growing adoption of emergency medical services (EMS), technological advancements in intra-osseous access devices, and investments in emergency healthcare infrastructure are among the key trends that are likely to affect the growth of the market.
• The highest opportunities are anticipated for powered drill segment, specifically in the U.S., on account of the presence of sophisticated emergency healthcare facilities, increasing number of trauma and heart attack cases, and the increased use of technologically advanced devices. North America is projected to hold a major share of the regional market, thanks to supportive reimbursement policies, increasing awareness regarding emergency care, and constant innovations among the key vendors of the market.
• For gaining any competitive advantage in the market, companies need to pay more attention on the development of light-weight, portable, and easy-to-use intraosseous infusion devices that offer better safety features and rapid insertion capabilities. In addition, strategic alliances with hospitals, ambulances, and military establishments, along with training of healthcare personnel, will become extremely important in helping to establish a strong market position.

Market Segmentation

• Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Manual
  • Impact Driven
  • Powered Drill
• Access Site Insights (Revenue, USD Mn, 2021 - 2033)
  • Sternum
  • Proximal Tibia
  • Distal Tibia
  • Calcaneus
  • Proximal Humerus
  • Others
• Age Insights (Revenue, USD Mn, 2021 - 2033)
  • Pediatrics
  • Adults
  • Geriatrics
• Application Insights (Revenue, USD Mn, 2021 - 2033)
  • Emergency Medical Situations
  • Trauma Care
  • Critical Care
  • Military and Défense
  • Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Emergency Medical Services (EMS)
  • Military and Defense Organizations
  • Ambulatory Surgical Centers (ASCs)
  • Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Teleflex Incorporated
  • BD
  • Cook Medical
  • SAM Medical
  • Argon Medical Devices, Inc.
  • PerSys Medical
  • Pyng Medical Corp.
  • Aero Healthcare
  • PAVmed Inc.
  • BIOPSYBELL S.R.L.

Sources

Primary Research Interviews

• Emergency medicine physicians, trauma surgeons, and critical care specialists from hospitals and trauma centers
• Emergency Medical Services (EMS) professionals and paramedics involved in pre-hospital emergency care
• Medical device manufacturers specializing in intraosseous infusion and vascular access technologies
• Hospital procurement managers and critical care administrators managing emergency medical device supply
• Military healthcare professionals and battlefield trauma care specialists
• Clinical researchers and investigators involved in emergency medicine and vascular access studies

Stakeholders

• Intraosseous Infusion Devices Manufacturers
• End-use Sectors
  • Hospitals and Trauma Centers
  • Emergency Medical Services (EMS)
  • Military and Defense Organizations
  • Ambulatory Surgical Centers
• Regulatory & Health Bodies: U.S. Food and Drug Administration (FDA) – medical device approvals and safety regulations, European Medicines Agency (EMA) – emergency care device regulatory framework, World Health Organization (WHO) – global injury and emergency care statistics, Centers for Disease Control and Prevention (CDC) – trauma and emergency healthcare guidelines, Central Drugs Standard Control Organization (CDSCO) – medical device regulations and approvals

Databases

• ClinicalTrials.gov – studies on intraosseous infusion devices and emergency vascular access technologies
• World Health Organization Global Health Observatory – trauma, injury, and emergency healthcare statistics
• PubMed – research on intraosseous access procedures, emergency care outcomes, and vascular access technologies

Magazines

• Emergency Medicine News – updates on emergency care technologies and trauma management
• Medical Device Network – developments in vascular access and infusion technologies
• NIH Research Matters – emergency medicine and trauma care research updates
• MedTech Dive – medical device innovation and healthcare technology trends

Journals

• Journal of Emergency Medicine
• The Lancet Emergency Medicine
• Critical Care Medicine
• American Journal of Emergency Medicine
• Resuscitation Journal

Newspapers

• The New York Times (Health Section) – coverage on emergency healthcare and trauma care trends
• The Guardian (Health & Science) – reporting on global injury burden and emergency response systems
• Financial Times – medical device industry trends and healthcare investments

Associations

• American College of Emergency Physicians (ACEP)
• Emergency Nurses Association (ENA)
• National Association of Emergency Medical Technicians (NAEMT)
• Society of Critical Care Medicine (SCCM)

Public Domain Sources

• National Institutes of Health (NIH) – research on emergency medicine and vascular access technologies
• Centers for Disease Control and Prevention (CDC) – trauma and emergency care statistics
• World Health Organization (WHO) – global injury and emergency healthcare data
• National health ministries (e.g., U.S., U.K., India, Australia) – emergency healthcare infrastructure and trauma burden statistics

Proprietary Elements

• CMI Data Analytics Tool, Proprietary CMI Existing Repository of information for last 10 years.